This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Traditional 503A compoundingpharmacies and 503B outsourcing manufacturers both serve as important partners for veterinary practices, providing patient-specific prescriptions and manufacturing bulk drugs for in-practice use and dispensing when allowed by state regulations. Our blog gives you a comprehensive look at the two.
The following blog is written by Epicur Pharma’s Advisory Council member Jamie Rauscher, LVT. Below, Jamie shares her perspective on the advancements in compounding based on her visit to the Stokes Healthcare facility. Being able to see these things in person gave me a whole new respect for their compoundingpharmacies.
Watch our most recent on-demand GFI webinar with Nicole Clausen, What Every Inventory Manager Needs to Know About Compounded Medications. Impending USP Guidelines on Beyond-Use Dates Coming in late 2023, new USP guidelines will limit Beyond-Use Dates (BUDs) on drugs from 503A compoundingpharmacies. Read our blog!
As Sam mentioned in her blog , the regions we each cover are large. Compoundingpharmacies, unlike 503Bs, are not required to test the final product. The doctor specifically uses Epicur, but a colleague in her practice had ordered a product from a compoundingpharmacy and, sadly, the pet died. Thanks, Branson!
link] In this insightful blog post, we delve into the diverse facets of Dr. Harris's remarkable career: Holistic Healthcare Visionary : Dr. Harris is not your typical healthcare professional. ⚡️ For more resources to get started, check out some of our other blog post content! Obviously, you're doing so through consulting.
The following blog is written by Epicur Pharmas Advisory Council member Nicole Clausen, CSSGB, CCFP. Nicole shares her perspective on the importance of choosing the right compoundingpharmacy to successfully manage your practices inventory. But, when it comes to compounded medications, there are many more factors to consider.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content